General Information of Drug Off-Target (DOT) (ID: OTYKFPKZ)

DOT Name Single-minded homolog 1 (SIM1)
Synonyms Class E basic helix-loop-helix protein 14; bHLHe14
Gene Name SIM1
Related Disease
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Cervical cancer ( )
Cervical carcinoma ( )
Complex neurodevelopmental disorder ( )
Depression ( )
Hypopituitarism ( )
Language disorder ( )
Lung adenocarcinoma ( )
Lung squamous cell carcinoma ( )
Metastatic malignant neoplasm ( )
Neoplasm ( )
Inherited obesity ( )
Obesity due to SIM1 deficiency ( )
Erectile dysfunction ( )
Intellectual disability ( )
Prader-Willi syndrome ( )
UniProt ID
SIM1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00010 ; PF00989 ; PF08447 ; PF06621
Sequence
MKEKSKNAARTRREKENSEFYELAKLLPLPSAITSQLDKASIIRLTTSYLKMRVVFPEGL
GEAWGHSSRTSPLDNVGRELGSHLLQTLDGFIFVVAPDGKIMYISETASVHLGLSQVELT
GNSIYEYIHPADHDEMTAVLTAHQPYHSHFVQEYEIERSFFLRMKCVLAKRNAGLTCGGY
KVIHCSGYLKIRQYSLDMSPFDGCYQNVGLVAVGHSLPPSAVTEIKLHSNMFMFRASLDM
KLIFLDSRVAELTGYEPQDLIEKTLYHHVHGCDTFHLRCAHHLLLVKGQVTTKYYRFLAK
HGGWVWVQSYATIVHNSRSSRPHCIVSVNYVLTDTEYKGLQLSLDQISASKPAFSYTSSS
TPTMTDNRKGAKSRLSSSKSKSRTSPYPQYSGFHTERSESDHDSQWGGSPLTDTASPQLL
DPADRPGSQHDASCAYRQFSDRSSLCYGFALDHSRLVEERHFHTQACEGGRCEAGRYFLG
TPQAGREPWWGSRAALPLTKASPESREAYENSMPHIASVHRIHGRGHWDEDSVVSSPDPG
SASESGDRYRTEQYQSSPHEPSKIETLIRATQQMIKEEENRLQLRKAPSDQLASINGAGK
KHSLCFANYQQPPPTGEVCHGSALANTSPCDHIQQREGKMLSPHENDYDNSPTALSRISS
PNSDRISKSSLILAKDYLHSDISPHQTAGDHPTVSPNCFGSHRQYFDKHAYTLTGYALEH
LYDSETIRNYSLGCNGSHFDVTSHLRMQPDPAQGHKGTSVIITNGS
Function Transcriptional factor that may have pleiotropic effects during embryogenesis and in the adult.

Molecular Interaction Atlas (MIA) of This DOT

19 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Breast cancer DIS7DPX1 Strong Biomarker [2]
Breast carcinoma DIS2UE88 Strong Biomarker [2]
Breast neoplasm DISNGJLM Strong Biomarker [3]
Cervical cancer DISFSHPF Strong Posttranslational Modification [1]
Cervical carcinoma DIST4S00 Strong Posttranslational Modification [1]
Complex neurodevelopmental disorder DISB9AFI Strong Autosomal dominant [4]
Depression DIS3XJ69 Strong Genetic Variation [5]
Hypopituitarism DIS1QT3G Strong Biomarker [6]
Language disorder DISTLKP7 Strong Genetic Variation [7]
Lung adenocarcinoma DISD51WR Strong Biomarker [8]
Lung squamous cell carcinoma DISXPIBD Strong Biomarker [9]
Metastatic malignant neoplasm DIS86UK6 Strong Genetic Variation [10]
Neoplasm DISZKGEW Strong Posttranslational Modification [1]
Inherited obesity DISVH4OT moderate Biomarker [11]
Obesity due to SIM1 deficiency DISQXLQ5 Supportive Autosomal recessive [12]
Erectile dysfunction DISD8MTH Limited Biomarker [13]
Intellectual disability DISMBNXP Limited Genetic Variation [14]
Prader-Willi syndrome DISYWMLU Limited Biomarker [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 19 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Single-minded homolog 1 (SIM1). [15]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Single-minded homolog 1 (SIM1). [18]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Single-minded homolog 1 (SIM1). [16]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Single-minded homolog 1 (SIM1). [17]
------------------------------------------------------------------------------------

References

1 Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.Diagn Cytopathol. 2018 Jan;46(1):15-21. doi: 10.1002/dc.23838. Epub 2017 Oct 24.
2 DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.Med Oncol. 2018 Sep 14;35(11):147. doi: 10.1007/s12032-018-1207-3.
3 Identification of 20 genes aberrantly methylated in human breast cancers.Int J Cancer. 2005 Sep 1;116(3):407-14. doi: 10.1002/ijc.21054.
4 Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
5 Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.Eur Neuropsychopharmacol. 2020 Feb;31:69-85. doi: 10.1016/j.euroneuro.2019.11.004. Epub 2019 Dec 6.
6 Endocrine phenotype of 6q16.1-q21 deletion involving SIM1 and Prader-Willi syndrome-like features.Am J Med Genet A. 2013 Dec;161A(12):3137-43. doi: 10.1002/ajmg.a.36149. Epub 2013 Aug 16.
7 Associations between oxytocin-related genes and autistic-like traits.Soc Neurosci. 2014;9(4):378-86. doi: 10.1080/17470919.2014.897995. Epub 2014 Mar 17.
8 Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma.Sci Rep. 2016 Oct 26;6:35807. doi: 10.1038/srep35807.
9 Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.J Comput Biol. 2020 Jul;27(7):1041-1054. doi: 10.1089/cmb.2019.0138. Epub 2019 Nov 11.
10 Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.FASEB J. 2012 Dec;26(12):4937-50. doi: 10.1096/fj.12-209502. Epub 2012 Aug 28.
11 Common variation in SIM1 is reproducibly associated with BMI in Pima Indians.Diabetes. 2009 Jul;58(7):1682-9. doi: 10.2337/db09-0028. Epub 2009 Apr 28.
12 Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features. J Clin Invest. 2013 Jul;123(7):3037-41. doi: 10.1172/JCI68035. Epub 2013 Jun 17.
13 GWAS Identifies Risk Locus for Erectile Dysfunction and Implicates Hypothalamic Neurobiology and Diabetes in Etiology.Am J Hum Genet. 2019 Jan 3;104(1):157-163. doi: 10.1016/j.ajhg.2018.11.004. Epub 2018 Dec 21.
14 Obesity with associated developmental delay and/or learning disability in patients exhibiting additional features: report of novel pathogenic copy number variants.Am J Med Genet A. 2013 Mar;161A(3):479-86. doi: 10.1002/ajmg.a.35761. Epub 2013 Feb 7.
15 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
16 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
17 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
18 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.